Market Research Logo

Uzbekistan Pharmaceuticals and Healthcare Report Q2 2016

Uzbekistan Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Non-communicable conditions will remain the leading contributors to Uzbekistan's burden of disease. Nevertheless, the country will be challenged in managing a tuberculosis epidemic and improving its relatively poor prognosis for infectious diseases control. Pharmaceutical companies with drug portfolios addressing both infectious diseases and chronic diseases will see commercial opportunities arise in Uzbekistan. However, we expect that this will be moderated by the low affordability of pharmaceuticals and the limited capacity of the Uzbek healthcare system to purchase medicines.

Headline Expenditure Projections

Pharmaceuticals: UZS2.78trn (USD956mn) in 2015 to UZS3.43trn (USD1.14bn) in 2016; 23.1% in local currency terms and 19.7% in US dollar terms. Forecast in US dollar terms revised upwards compared to the previous quarter.

Healthcare: UZS10.7trn (USD4.17bn) in 2015 to UZS12.8trn (USD4.27bn) in 2016; 19.2% in local currency terms and 2.2% in US dollar terms. Forecast in local currency terms revised upwards compared to the previous quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Uzbekistan 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Uzbekistan 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Uzbekistan 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Uzbekistan 2014-2020)
Industry Risk/Reward Index
Central And Eastern Europe Risk/Reward Index
Uzbekistan Risk/Reward Index
Rewards
Risks
Regulatory Review
Counterfeit Drugs
Intellectual Property Issues
Pricing And Reimbursement
Market Overview
Healthcare Sector
Healthcare Provision
Health Insurance Sector
Healthcare Sector Reforms
Research And Development
Clinical Trials
International Cooperation
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Leading Domestic Players
Table: List Of Companies In Uzpharmsanoat SJSC (as of October 7 2013)
Pharmaceutical Sector Reforms
Foreign Pharmaceutical Industry
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Asklepiy Pharmaceutical Company
Jurabek Laboratories
Uzpharmsanoat
Demographic Forecast
Table: Population Headline Indicators (Uzbekistan 1990-2025)
Table: Key Population Ratios (Uzbekistan 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Uzbekistan 1990-2025)
Table: Population By Age Group (Uzbekistan 1990-2025)
Table: Population By Age Group % (Uzbekistan 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report